Livongo Health, Inc.

Of course.

Livongo's exit, acquisition by Teladoc, combined value of $50 billion.

Today, that company's worth a billion.

It's down 98%.

I was like, wait a minute.

Like in our first year, we were delivering the world's best outcomes by a lot.

Like Livongo back then was delivering a one percentage point reduction in hemoglobin A1C in six months.

And they had published this.